Literature DB >> 32195757

The mKATP Channels and protein-kinase C Are Involved in the Cardioprotective Effects of Genistein on Estrogen-Deficient Rat Hearts Exposed to Ischemia/Reperfusion: Energetic Study.

Germán A Colareda1, María Inés Ragone1, Patricia Bonazzola2, Alicia E Consolini1.   

Abstract

Estrogenic deficiency is considered a risk of coronary disease in women. The phytoestrogen genistein could be a safe preventive strategy. The first aim of this work was to validate a model of cardiac stunning in which natural estrogenic deficiency rats, ie, adult young male (YM) and aged female (AgF), are compared with young female rats (YF). The second aim was to study whether the in vivo administration of genistein prevents the stunning in estrogenic deficiency rats. The third aim was to evaluate whether in our estrogenic deficiency model exists a synergy between genistein and estradiol. The fourth aim was to characterize the underlying mechanisms of genistein. Stunning was induced by ischemia/reperfusion (I/R) in isolated hearts inside a calorimeter. The left ventricular pressure (P) and total heat rate (Ht) were simultaneously measured, while diastolic contracture and muscle economy (P/Ht) were calculated. During R, P/Ht and P recovered less in AgF and YM than in YF rat hearts. Genistein through i.p. (GST-ip) improved P and P/Ht in AgF and YM, but not in YF. In YM, the cardioprotections of GST-ip and estradiol were synergistic. After ischemia, GST-ip increased SR Ca leak causing diastolic contracture. The GST-ip cardioprotection neither was affected by blockade of PI3K-Akt, NO synthases, or phosphatases, but it was sensitive to blockade of protein-kinase C and mKATP channels. Results suggest that (1) estrogenic deficiency worsens cardiac stunning, (2) GST-ip was more cardioprotective in estrogenic deficiency and synergistic with estradiol, and (3) cardioprotection of GST-ip depends on the protein-kinase C and mKATP channel pathway activation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32195757     DOI: 10.1097/FJC.0000000000000816

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  A Systematic Review and Meta-Analysis of Phytoestrogen Protects Against Myocardial Ischemia/Reperfusion Injury: Pre-Clinical Evidence From Small Animal Studies.

Authors:  Yumeng Wang; Xintian Shou; Zongjing Fan; Jie Cui; Donghua Xue; Yang Wu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  Proteomics Revealed That Mitochondrial Function Contributed to the Protective Effect of Herba Siegesbeckiae Against Cardiac Ischemia/Reperfusion Injury.

Authors:  Xiaohong Wei; Yuzhuo Wu; Haie Pan; Qian Zhang; Ke He; Guiyang Xia; Huan Xia; Sheng Lin; Hong-Cai Shang
Journal:  Front Cardiovasc Med       Date:  2022-07-06

3.  Lepidium meyenii (maca) and soy isoflavones reduce cardiac stunning of ischemia-reperfusion in rats by mitochondrial mechanisms.

Authors:  Germán A Colareda; Soledad I Matera; Matías Bayley; María Inés Ragone; María Luján Flores; Osvaldo León Córdoba; Alicia E Consolini
Journal:  J Tradit Complement Med       Date:  2021-04-02

Review 4.  Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective.

Authors:  Walter Ángel Trujillo-Rangel; Leonel García-Valdés; Miriam Méndez-Del Villar; Rolando Castañeda-Arellano; Sylvia Elena Totsuka-Sutto; Leonel García-Benavides
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

Review 5.  Functional Regulation of KATP Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases.

Authors:  Zhicheng Wang; Weikang Bian; Yufeng Yan; Dai-Min Zhang
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.